Results of the performed experiment with osteosarcoma cell lines showed that parthenolide, an NF-κB signaling inhibitor, acted synergistically with RT, providing a significant reduction of the number of viable cancer cells in the analyzed samples. Here, NFKB1 is linked to osteosarcoma.